Literature DB >> 17306743

Role and mechanisms of CD4+CD25+ regulatory T cells in the induction and maintenance of transplantation tolerance.

Zhang Yong1, Liu Chang, Yang Xiao Mei, Lv Yi.   

Abstract

To gain transplantation tolerance between donor organs and hosts is the ultimate goal of all sorts of organ transplantations. Induction of regulatory T cells has been demonstrated to lead to transplantation tolerance. This paper will review subsets of regulatory T cells, the role and mechanisms of CD4(+)CD25(+) regulatory T cells (Tregs) in graft rejection and tolerance, pathway used by Tregs to recognized alloantigens, pathways of Tregs homing into the graft and effects of immunosuppression on Tregs. It was well known that Tregs play a pivotal role in transplantation tolerance. The mechanisms by which Tregs exert their regulatory effect in the induction and maintenance of transplantation tolerance, anthropogenically, consist of physical cell-to-cell contact with potential target cells, autocrine and paracrine properties. ICAM-1, TGF-beta, CTLA-4, GITR and OX40 (CD134), etc. are involved in the regulatory function of Tregs through cell-to-cell contact mechanism. IL-10 and TGF-beta are two important soluble mediators involved in the autocrine mechanism by which Tregs exert their regulatory function. Paracrine properties refer to re-educate potentially destructive alloresponsive T cells to gain regulatory function. All that discussed above could illustrate, at least partially, how naturally occurring Tregs exert their regulatory function in vivo as they constitute only 5-10% of peripheral CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17306743     DOI: 10.1016/j.trim.2006.09.005

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  19 in total

1.  Regulatory T-cell subset analysis and profile of interleukin (IL)-10, IL-17 and interferon-gamma cytokine-producing cells in kidney allograft recipients with donor cells infusion.

Authors:  Moslem Ranjbar; Ghasem Solgi; Mousa Mohammadnia; Behrouz Nikbin; Gholamreza Pourmand; Bita Ansaripour; Aliakbar Amirzargar
Journal:  Clin Exp Nephrol       Date:  2012-08       Impact factor: 2.801

Review 2.  Do cannabinoids have a therapeutic role in transplantation?

Authors:  Mitzi Nagarkatti; Sadiye Amcaoglu Rieder; Venkatesh L Hegde; Shunsuke Kanada; Prakash Nagarkatti
Journal:  Trends Pharmacol Sci       Date:  2010-06-28       Impact factor: 14.819

3.  Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts.

Authors:  Todd V Brennan; Qizhi Tang; Feng-Chun Liu; Vunghi Hoang; Mingying Bi; Jeffrey A Bluestone; Sang-Mo Kang
Journal:  J Surg Res       Date:  2011-04-05       Impact factor: 2.192

4.  Ex vivo expansion of human Tregs by rabbit ATG is dependent on intact STAT3-signaling in CD4⁺ T cells and requires the presence of monocytes.

Authors:  O Boenisch; M Lopez; W Elyaman; C N Magee; U Ahmad; N Najafian
Journal:  Am J Transplant       Date:  2012-03-05       Impact factor: 8.086

Review 5.  Challenges in clinical design of immunotherapy trials for malignant glioma.

Authors:  Cleo E Rolle; Sadhak Sengupta; Maciej S Lesniak
Journal:  Neurosurg Clin N Am       Date:  2010-01       Impact factor: 2.509

6.  Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients.

Authors:  Joanna Ashton-Chess; Emilie Dugast; Robert B Colvin; Magali Giral; Yohann Foucher; Anne Moreau; Karine Renaudin; Christophe Braud; Anne Devys; Sophie Brouard; Jean-Paul Soulillou
Journal:  J Am Soc Nephrol       Date:  2009-04-08       Impact factor: 10.121

7.  CD8+ CD122+ regulatory T cells contain clonally expanded cells with identical CDR3 sequences of the T-cell receptor β-chain.

Authors:  Yusuke Okuno; Ayako Murakoshi; Masashi Negita; Kazuyuki Akane; Seiji Kojima; Haruhiko Suzuki
Journal:  Immunology       Date:  2013-07       Impact factor: 7.397

8.  Connective tissue growth factor promotes fibrosis downstream of TGFbeta and IL-6 in chronic cardiac allograft rejection.

Authors:  A J Booth; K Csencsits-Smith; S C Wood; G Lu; K E Lipson; D K Bishop
Journal:  Am J Transplant       Date:  2009-09-25       Impact factor: 8.086

9.  Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection.

Authors:  Susan M Faust; Guanyi Lu; Bernard L Marini; Weiping Zou; David Gordon; Yoichiro Iwakura; Yasmina Laouar; D Keith Bishop
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

10.  TGFbeta neutralization within cardiac allografts by decorin gene transfer attenuates chronic rejection.

Authors:  Susan M Faust; Guanyi Lu; Sherri C Wood; D Keith Bishop
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.